Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China

被引：0
|
作者：
Zhang, Puhong [1 ]
Zhang, Heng [1 ]
Zhu, Dongshan [1 ]
Li, Xian [1 ]
Ji, Jiachao [1 ]
Zhao, Fang [1 ]
Lu, Juming [2 ]
Jia, Weiping [3 ]
Ji, Linong [1 ,4 ]
机构：
[1] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[3] Shanghai 6th Hosp, Dept Endocrinol, Shanghai, Peoples R China
[4] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
989017
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Insulin detemir and insulin aspart:: A promising basal-bolus regimen for type 2 diabetes (vol 66, pg 193, 2004)
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hâncu, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (01) : 112 - 112
  • [42] Comparison of canagliflozin and liraglutide as a replacement for bolus insulin in type 2 diabetes patients well-controlled by basal-bolus insulin
    Kumashiro, N.
    Ando, Y.
    Shigiyama, F.
    Igarashi, H.
    Yoshikawa, F.
    Uchino, H.
    Yoshino, H.
    Miyagi, M.
    Ikehara, K.
    Hirose, T.
    DIABETOLOGIA, 2018, 61 : S126 - S126
  • [43] BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA
    Bueno, Elvio
    Benitez, Aldo
    Vera Rufinelli, Jazmin
    Figueredo, Rafael
    Alsina, Shirley
    Ojeda, Aldo
    Samudio, Sandra
    Caceres, Mirta
    Arguello, Rocio
    Romero, Fabiola
    Echague, Gloria
    Pasquel, Francisco
    Umpierrez, Guillermo E.
    ENDOCRINE PRACTICE, 2015, 21 (07) : 807 - 813
  • [44] Treatment Patterns and Characteristics of Patients with Type 2 Diabetes (T2D) Managed with Basal-Bolus Therapy in the
    Van Brunt, Kate
    Curtis, Bradley H.
    Chalkiadaki, Corina
    Balogh, Elemer
    Ivanyi, Tibor
    Raluy, Mireia
    Maclachlan, Sharon
    DIABETES, 2015, 64 : A696 - A697
  • [45] Italian experience trial for the implementation of LANTUS in basal-bolus regimen in patients with type 1 diabetes
    Brunetti, Paolo
    Muggeo, Michele
    Cattin, Luigi
    Arcangeli, Adolfo
    Pozzilli, Paolo
    Provenzano, Vincenzo
    Francesconi, Andrea
    Calatola, Pasqualino
    Santeusanio, Fausto
    DIABETES, 2007, 56 : A558 - A558
  • [46] Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS study
    Raccah, D.
    Haak, T. J.
    Huet, D.
    Monnier, L.
    Robertson, D.
    Labard, P.
    Soler, J.
    Penfornis, A.
    DIABETES & METABOLISM, 2012, 38 (06) : 507 - 514
  • [47] Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study
    Fritsche, A.
    Larbig, M.
    Owens, D.
    Haering, H.-U.
    DIABETES OBESITY & METABOLISM, 2010, 12 (02): : 115 - 123
  • [48] Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs When and for whom?
    Mosenzon, Ofri
    Raz, Itamar
    DIABETES CARE, 2013, 36 : S212 - S218
  • [49] Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
    Attri, Bhawna
    Goyal, Alpesh
    Gupta, Yashdeep
    Tandon, Nikhil
    DIABETES THERAPY, 2020, 11 (09) : 2177 - 2194
  • [50] Glargine basal-bolus insulin regimen versus insulin pump therapy: comparison of glycemic control
    Starkman, Harold
    Frydman, Emily
    Bustami, Rami
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (5-6): : 369 - 371
12345